Greg Dwyer Email
Head Business Development . Orum Therapeutics
How to contact Greg Dwyer
Join and see Greg's contact info for free!Current Roles
Employees:
54Revenue:
$4.2MAbout
Orum Therapeutics is a private biotech developing next-generation TPD technologies. Orum's novel and proprietary next generation targeted protein degradation (TPD) platform, TPD2 AnDC (Antibody neoDegrader Conjugate), enables tumor-specific targeting for multiple indications. Orum was founded in 2016 and has labs and offices operating out of Daejeon, South Korea, and Cambridge, MA, US.Orum Therapeutics Address
20 Acorn Park DriveDaejeon, --Select--